Search Results
Mar 19, 2026, 08:30 ET DPL LLC Announces Amendments to and Further Extension of Consent Solicitation
personnel; (vi) potential adverse reactions or changes to business relationships resulting from the announcement or completion of the Transaction; (vii) continued availability of capital and financing and rating agency actions; (viii) certain restrictions during the pendency of the Transaction that may
More news about: DPL LLC
Mar 19, 2026, 08:30 ET IPALCO Enterprises, Inc. Announces Amendments to and Further Extension of Consent Solicitations
personnel; (vi) potential adverse reactions or changes to business relationships resulting from the announcement or completion of the Transaction; (vii) continued availability of capital and financing and rating agency actions; (viii) certain restrictions during the pendency of the Transaction that may
More news about: IPALCO Enterprises
Mar 19, 2026, 08:30 ET AES Announces Expiration of Consent Solicitation for its 2032 Notes and Amendment and Extension of Consent Solicitations for its 2028 Notes, 2030 Notes and 2031 Notes
personnel; (vi) potential adverse reactions or changes to business relationships resulting from the announcement or completion of the Transaction; (vii) continued availability of capital and financing and rating agency actions; (viii) certain restrictions during the pendency of the Transaction that may
More news about: The AES Corporation
Mar 19, 2026, 08:15 ET CORVEX ANNOUNCES CLOSING OF ALL-STOCK MERGER
independent registered public accounting firm for the year ending December 31, 2026, (vi) the approval of the Corvex, Inc. 2026 Employee Incentive Plan and (vii) the approval of the Corvex, Inc. 2026 Employee Stock Purchase Plan. Upon shareholder approval of the Conversion Proposal, each share of Series C Preferred
More news about: Corvex
Mar 19, 2026, 08:15 ET CORVEX ANNOUNCES CLOSING OF ALL-STOCK MERGER
independent registered public accounting firm for the year ending December 31, 2026, (vi) the approval of the Corvex, Inc. 2026 Employee Incentive Plan and (vii) the approval of the Corvex, Inc. 2026 Employee Stock Purchase Plan. Upon shareholder approval of the Conversion Proposal, each share of Series C Preferred
More news about: Movano
Mar 19, 2026, 06:30 ET Cardinal Infrastructure Group Inc. Announces Full Year 2025 Results and Affirms 2026 Guidance
(iv) non-routine revenue impact from customer claims, (v) non-routine loss on extinguishment and refinancing costs, (vi) stock-based compensation, (vii) non-routine IPO related travel and compensation, and (viii) other non-routine gains and charges that we do not believe reflect our underlying business
More news about: Cardinal Infrastructure Group Inc.
Mar 17, 2026, 10:01 ET Epidermolysis Bullosa Market Set for Significant Upswing During the Forecast Period (2025-2034) Amid Rising Therapeutic Advancements | DelveInsight
fibroblasts, which are genetically engineered using a self-inactivating lentiviral vector carrying the COL7A1 gene, enabling the cells to produce type VII collagen. The therapy is delivered through intradermal injections into the superficial papillary dermis of chronic wounds, where the introduced COL7
More news about: DelveInsight Business Research, LLP
Mar 16, 2026, 16:41 ET Summit Midstream Corporation Reports Fourth Quarter and Full-Year 2025 Financial and Operating Results, Permian and Rockies Segment Growth Update and Provides Full-Year 2026 Guidance
volume commitments ("MVC") shortfall payments, (v) adjustments related to capital reimbursement activity, (vi) unit-based and noncash compensation, (vii) impairments and (viii) other noncash expenses or losses, less other noncash income or gains.
More news about: Summit Midstream Corporation
Mar 16, 2026, 16:30 ET Adecoagro S.A.: Strategic acquisition of Profertil drives pro forma results. Adjusted EBITDA stood at $276.7 million in 2025, $467.2 million pro forma.
(vi) our plans relating to acquisitions, joint ventures, strategic alliances or divestitures, and to consolidate our position in different businesses; (vii) the efficiencies, cost savings and competitive advantages resulting from acquisitions; (viii) the implementation of our financing strategy, capital
More news about: Adecoagro S.A.
Mar 16, 2026, 16:23 ET Saul Centers Declares Quarterly Dividends
ability to estimate the impact of such changes, (vi) the level and volatility of interest rates and management's ability to estimate the impact thereof, (vii) the availability of suitable acquisition, disposition, development and redevelopment opportunities, and risks related to acquisitions not performing
More news about: Saul Centers, Inc.
Mar 16, 2026, 13:18 ET Buscar Company Advances Key Permitting Milestones for Treasure Canyon Mine
all; (vi) risks inherent in mineral exploration, including the possibility that further work will not result in the establishment of mineral reserves; (vii) uncertainty regarding the results of technical assessments and feasibility studies; (viii) dependence on third-party consultants and qualified persons;
More news about: Buscar Company (CGLD)
Mar 16, 2026, 10:43 ET VinFast Reports Preliminary and Unaudited Fourth Quarter and Full Year 2025 Financial Results
reputation, public credibility, and consumer confidence in its business being harmed by negative publicity; (vi) competition in the automotive industry; (vii) the ability of the Company to obtain components and raw materials according to schedule at acceptable prices, quality, and volumes from its suppliers;
More news about: Vinfast Auto LLC
Mar 16, 2026, 08:30 ET AES Announces Amendments to and Further Extension of Consent Solicitations
personnel; (vi) potential adverse reactions or changes to business relationships resulting from the announcement or completion of the Transaction; (vii) continued availability of capital and financing and rating agency actions; (viii) certain restrictions during the pendency of the Transaction that may
More news about: The AES Corporation
Mar 16, 2026, 08:30 ET DPL LLC Announces Amendments to and Further Extension of Consent Solicitation
personnel; (vi) potential adverse reactions or changes to business relationships resulting from the announcement or completion of the Transaction; (vii) continued availability of capital and financing and rating agency actions; (viii) certain restrictions during the pendency of the Transaction that may
More news about: DPL LLC
Mar 16, 2026, 08:30 ET IPALCO Enterprises, Inc. Announces Amendments to and Further Extension of Consent Solicitations
personnel; (vi) potential adverse reactions or changes to business relationships resulting from the announcement or completion of the Transaction; (vii) continued availability of capital and financing and rating agency actions; (viii) certain restrictions during the pendency of the Transaction that may
More news about: IPALCO Enterprises
Mar 16, 2026, 06:26 ET GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth
on long-term assets;(v) foreign exchange gains or losses;(vi) fair value gains or losses on non-current financial assets;(vii) unrealized financing costs related to equity financing activities;(viii) share of losses from Legend Biotech and service fees related to deconsolidation;
More news about: GenScript Biotech Corporation
Mar 16, 2026, 06:10 ET GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth
on long-term assets;(v) foreign exchange gains or losses;(vi) fair value gains or losses on non-current financial assets;(vii) unrealized financing costs related to equity financing activities;(viii) share of losses from Legend Biotech and service fees related to deconsolidation;
More news about: GenScript Biotech Corporation
Mar 15, 2026, 21:00 ET Zepp Health Corporation Reports Fourth Quarter and Full Year 2025 Unaudited Financial Results
investments, (iv) impairment loss from long-term investments, (v) income/(loss) from equity method investments, (vi) income tax (benefit)/expense, and (vii) interest income and interest expense. Adjusted net income/(loss) attributable to Zepp Health Corporation is a non-GAAP measure, which excludes
More news about: Zepp Health Corp.
Mar 12, 2026, 20:06 ET Chegada do OPPO Find X9 Pro no Brasil marca a entrada no segmento premium de smartphones
água: área circular de aprox. 120 mm de diâmetro a 2,5 m do bocal; (v) distância do bocal ao invólucro: 2,5–3 m; (vi) duração do teste: 3 minutos; (vii) diferença de temperatura da água em relação à amostra ≤ 5K.Condições de teste IP68: (i) água doce parada, profundidade de 1,5 m; (ii) duração
More news about: OPPO BRASIL
Mar 12, 2026, 16:30 ET LivePerson Announces Fourth Quarter 2025 Financial Results
costs; (vi) non-GAAP sales and marketing expenses, or sales and marketing expenses excluding stock-based compensation and leadership transition costs; (vii) non-GAAP general and administrative expenses, or general and administrative expenses excluding stock-based compensation, litigation, consulting and
More news about: LivePerson
Mar 12, 2026, 16:15 ET Nektar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
markets; (vi) a Fast Track designation does not increase the likelihood that rezpegaldesleukin will receive marketing approval in the United States; (vii) patents may not issue from our patent applications for our drug candidates, patents that have issued may not be enforceable, or additional intellectual
More news about: Nektar Therapeutics
Mar 12, 2026, 16:05 ET American Outdoor Brands, Inc. Reports Third Quarter Fiscal 2026 Financial Results
assets held for sale, (iv) non-recurring inventory reserve adjustment, (v) emerging growth status transition costs, (vi) technology implementation, (vii) income tax adjustments, (viii) interest income, (ix) income tax expense, and (x) depreciation and amortization; and (2) the non-GAAP measures that exclude
More news about: American Outdoor Brands, Inc.
Mar 12, 2026, 08:30 ET AES Announces Extension of Expiration Time for Previously Announced Consent Solicitations
personnel; (vi) potential adverse reactions or changes to business relationships resulting from the announcement or completion of the Transaction; (vii) continued availability of capital and financing and rating agency actions; (viii) certain restrictions during the pendency of the Transaction that may
More news about: The AES Corporation
Mar 12, 2026, 08:30 ET IPALCO Enterprises, Inc. Announces Extension of Expiration Time for Previously Announced Consent Solicitations
personnel; (vi) potential adverse reactions or changes to business relationships resulting from the announcement or completion of the Transaction; (vii) continued availability of capital and financing and rating agency actions; (viii) certain restrictions during the pendency of the Transaction that may
More news about: IPALCO Enterprises
Mar 12, 2026, 08:30 ET DPL LLC Announces Extension of Expiration Time for Previously Announced Consent Solicitation
personnel; (vi) potential adverse reactions or changes to business relationships resulting from the announcement or completion of the Transaction; (vii) continued availability of capital and financing and rating agency actions; (viii) certain restrictions during the pendency of the Transaction that may
More news about: DPL LLC